Clin2
NCT07616648Possibly a fitRecruiting

How Opioid Pain Drugs Affect Sleep and Mood in Cancer Patients

Moderate to Severe Cancer Pain

Part of Pain clinical trials.

This study examines how opioid medications (strong pain relievers) impact sleep quality and emotional well-being in cancer patients with moderate to severe pain. Researchers will track your sleep patterns and mood to better understand these side effects.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
200 people
Ages
18 years to 75 years
Study type
Observational

Who can take part

  • You have a confirmed cancer diagnosis and moderate to severe cancer pain (rated 4 or higher on a pain scale)
  • You are between 18 and 75 years old
  • You have been taking a stable dose of opioid pain medication for at least one week with good pain control
  • You can complete questionnaires and wear a sleep-tracking wristband during the study
  • You have adequate liver and kidney function and are expected to live at least 3 months
  • You have no history of opioid, alcohol, or drug abuse

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06633432Not yet recruiting
Sleep quality and pain after lung cancer surgery

This study looks at how well patients sleep and how much pain they feel after surgery to remove lung cancer. It aims to find ways to improve recovery and comfort after the operation.

Shanghai, Shanghai Municipality
NCT07869797Not yet recruiting
outpatient pain control with oxycontin for cancer patients

This study tests how well and how safely OxyContin, a pain medicine, works when started at home (outpatient) for people with moderate to severe cancer pain. It aims to help patients manage pain more easily while staying at home.

Beijing
NCT05265052Not yet recruiting· Phase 2
Pain relief study for cancer patients with moderate to severe pain

This study tests whether a new pain medication called 3D1002, when combined with a long-acting opioid, can better manage moderate to severe cancer pain compared to the opioid alone. The goal is to find a more effective way to reduce pain without increasing side effects.

NCT06345872Recruiting
Better sleep to help reduce opioid use for chronic pain

This study tests a sleep improvement program to help people with chronic widespread pain reduce or stop their opioid pain medication. If you want to cut back on opioids and have trouble sleeping, this treatment might be a good fit.

Tampa, Florida
NCT07658677Not yet recruiting· Phase 1/Phase 2
Cannabis gummy for improving sleep in cancer patients

This study tests whether a cannabis gummy can improve sleep and quality of life for people with cancer. You would take a gummy nightly, wear a fitness tracker, and answer short surveys about your sleep and well-being.

Columbus, Ohio
NCT07565974Not yet recruiting· Phase 2
Cannabis for improving sleep in people with cancer

This study is testing whether taking a cannabis compound (THC with or without CBD) can improve sleep quality for people with solid organ cancers. If you have moderate-to-severe insomnia and are interested in a non-drug option, you might qualify.

Rochester, Minnesota

Hear when a new Moderate to Severe Cancer Pain trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.